Vicasol
Vikasol is a synthetic form of Vitamin K, known as Menadione sodium bisulfite. It is primarily used to address Vitamin K deficiency, which can lead to issues with blood clotting. The medication is available in tablet form and works by promoting the synthesis of clotting factors. It is commonly prescribed for conditions that require enhanced blood coagulation. Vikasol can be particularly beneficial in cases of hypoprothrombinemia or when there is a risk of excessive bleeding due to low Vitamin K levels. The tablets are easy to administer, ensuring effective management of the deficiency.Active substance:
Menadione sodium bisulfitePharmachologic effect:
Vikasol is a synthetic water-soluble analog of vitamin K, which plays a crucial role in the synthesis of prothrombin and other clotting factors. It helps in the normalization of blood coagulation processes.Indications:
- Hypoprothrombinemia due to vitamin K deficiency
- Bleeding associated with hypoprothrombinemia
- Prevention of bleeding in newborns
- Preparation for surgical interventions in patients with vitamin K deficiency
Contraindications:
- Hypersensitivity to menadione or any component of the drug
- Thromboembolic disease
- Hypercoagulability
- Hemolytic disease of the newborn
Side effects:
In order of decreasing probability: Allergic reactions, Bronchospasm, Skin rash, Itching, Erythema, Dizziness, Flushing
Dosing and Administration:
The recommended dose for adults is 10-15 mg per day. For children, the dose is determined by the physician based on age and body weight. The tablets should be taken orally with water, preferably after meals.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Vicasol
in Cyrillic : Викасол
SUBSTANCE
Menadione sodium bisulfite
DOSAGE FORM
tablets
